{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:17:17Z","timestamp":1767835037917,"version":"3.49.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T00:00:00Z","timestamp":1376438400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0071254","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T02:52:27Z","timestamp":1376535147000},"page":"e71254","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Higher Levels of Neutralizing Antibodies against KSHV in KS Patients Compared to Asymptomatic Individuals from Zambia"],"prefix":"10.1371","volume":"8","author":[{"given":"Pankaj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nithal Y.","family":"Kuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veenu","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemence","family":"Marimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle M.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chipepo","family":"Kankasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,8,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi&apos;s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"E Cesarman","year":"1995","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi&apos;s sarcoma","volume":"266","author":"Y Chang","year":"1994","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi&apos;s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman&apos;s disease","volume":"86","author":"J Soulier","year":"1995","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1359-6101(97)00037-3","article-title":"Kaposi&apos;s sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents","volume":"9","author":"B Ensoli","year":"1998","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0190-9622(90)70169-I","article-title":"Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi&apos;s sarcoma","volume":"22","author":"AE Friedman-Kien","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/bjc.1998.717","article-title":"The geographical distribution of Kaposi&apos;s sarcoma and of lymphomas in Africa before the AIDS epidemic","volume":"78","author":"P Cook-Mozaffari","year":"1998","journal-title":"Br J Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1468-1293.2006.00395.x","article-title":"The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta","volume":"7","author":"S Gingues","year":"2006","journal-title":"HIV Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e4222","DOI":"10.1371\/journal.pone.0004222","article-title":"Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda","volume":"4","author":"C Johnston","year":"2009","journal-title":"PLoS ONE"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Schwartz RA, Micali G, Nasca MR, Scuderi L (2008) Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol 59: 179\u2013206; quiz 207\u2013178.","DOI":"10.1016\/j.jaad.2008.05.001"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/(SICI)1097-0215(19981023)79:5<481::AID-IJC6>3.0.CO;2-X","article-title":"The Epstein-Barr virus (EBV) major envelope glycoprotein gp350\/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases","volume":"79","author":"J Xu","year":"1998","journal-title":"Int J Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1086\/386371","article-title":"Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma","volume":"189","author":"LE Kimball","year":"2004","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jmv.20167","article-title":"Comparison of serologic responses between Kaposi&apos;s sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus","volume":"74","author":"N Inoue","year":"2004","journal-title":"J Med Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1086\/314512","article-title":"Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi&apos;s sarcoma (KS) and mother-child pairs with KS","volume":"178","author":"J He","year":"1998","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ijc.10817","article-title":"The sero-epidemiology of Kaposi&apos;s sarcoma-associated herpesvirus (KSHV\/HHV-8) in adults with cancer in Uganda","volume":"103","author":"R Newton","year":"2003","journal-title":"Int J Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/aje\/kwq465","article-title":"The Zambia Children&apos;s KS-HHV8 Study: rationale, study design, and study methods","volume":"173","author":"V Minhas","year":"2011","journal-title":"Am J Epidemiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1128\/CVI.00487-07","article-title":"Development of an immunofluorescence assay using recombinant proteins expressed in insect cells to screen and confirm presence of human herpesvirus 8-specific antibodies","volume":"15","author":"V Minhas","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.virol.2004.03.049","article-title":"Use of the red fluorescent protein as a marker of Kaposi&apos;s sarcoma-associated herpesvirus lytic gene expression","volume":"325","author":"J Vieira","year":"2004","journal-title":"Virology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/00002030-200009290-00006","article-title":"Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi&apos;s sarcoma clinical stage","volume":"14","author":"TB Campbell","year":"2000","journal-title":"AIDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00002030-199602000-00007","article-title":"Kaposi&apos;s sarcoma-associated herpesvirus infection prior to onset of Kaposi&apos;s sarcoma","volume":"10","author":"PS Moore","year":"1996","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(95)91619-9","article-title":"Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi&apos;s sarcoma","volume":"346","author":"D Whitby","year":"1995","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1128\/JVI.01149-09","article-title":"Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression","volume":"83","author":"A Piantadosi","year":"2009","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/JVI.02036-08","article-title":"Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection","volume":"83","author":"DN Sather","year":"2009","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/315039","article-title":"Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi&apos;s sarcoma","volume":"180","author":"TR O'Brien","year":"1999","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<543::AID-IJC12>3.0.CO;2-7","article-title":"Risk factors for Kaposi&apos;s-sarcoma-associated herpesvirus (KSHV\/HHV-8) seropositivity in a cohort of homosexual men, 1981\u20131996","volume":"77","author":"M Melbye","year":"1998","journal-title":"Int J Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jmv.21987","article-title":"KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection","volume":"83","author":"SG Parisi","year":"2011","journal-title":"J Med Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood.V92.1.53.413k30_53_58","article-title":"Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi&apos;s sarcoma patients using a whole virus enzyme-linked immunosorbent assay","volume":"92","author":"LG Chatlynne","year":"1998","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/sj.bjc.6603100","article-title":"A prospective study of Kaposi&apos;s sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1","volume":"94","author":"R Newton","year":"2006","journal-title":"Br J Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0071254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T00:03:58Z","timestamp":1596326638000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0071254"}},"subtitle":[],"editor":[{"given":"Thomas F.","family":"Schulz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,14]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0071254","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,14]]}}}